Efficacy, safety and toleration of fluconazole suppositories in the treatment of oral candidosis

Mycoses

Volumn 42, Issue 4, 1999, Pages 269-272

  Plettenberg, A ^a   Stoehr, A ^a   Heise, W ^b   Schlote, F ^c   Sarnow, E ^d   Migdal, M ^e  

^a DEPARTMENT OF CARDIOLOGY   (Germany)

^b Vivantes Auguste Viktoria Klinikum   (Germany)

^c Specialist in Internal Medicine   (Germany)

^d PFIZER INC   (United States)

^e CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

Antimycotic chemotherapy; Candidosis; Fluconazole; Oral infection; Suppository preparation

Indexed keywords

FLUCONAZOLE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GEOTRICHUM CANDIDUM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUPPOSITORY; THRUSH; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDIASIS, ORAL; CAPSULES; FEMALE; FLUCONAZOLE; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; SUPPOSITORIES; TIME FACTORS; TREATMENT OUTCOME;

CANDIDA ALBICANS; CANDIDA GLABRATA; GALACTOMYCES GEOTRICHUM; GEOTRICHUM;

EID: 0032788934     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0507.1999.00452.x     Document Type: Article

References (13)

1. Selik, R. M., Starcher, E. T. & Curran, J. W. (1987) Opportunistic diseases reported in AIDS patients, frequencies, associations, and trends. AIDS 1, 175-182.
2. Nightengale, S. D., Cal, S. X., Peterson, D. M. et al. (1992) Primary prophylaxis with fluconazole against systemic fungal infections in HIV-positive patients. Current Sci. 6, 191-194.
3. Just-Nübling, G., Gentschew, G., Meissner, K. et al. (1991) Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients. Eur J. Clin. Microbiol. Infect Dis. 10, 917-921.
4. Winston, D. J., Chandrasckar, P. H., Lazarus, H. M. et al. (1993) Fluconazole prophylaxis of fungal infection in patients with acute leukemia. Ann. Int Med. 118, 495-503.
5. Laine, L., Dretler, R. H., Conicas, C. N. et al. (1992) Fluconazole compared with ketoconzaole for the treatment of Candida esophagus in AIDS. Ann. Int. Med. 117, 655-660.
6. Meunier, F., Aoun, M. & Gerard, M. (1990) Therapy for oropharyngeal candidiasis in the immuno-compromised host: a randomized double-blind study of fluconazole vs. ketoconazole. Rev. of Infect Dis 12 (Suppl. 3), 364-368.
7. van der Bijl, P. & Arendorf, T. M. (1993) Itraconazole and fluconazole in oropharyngeal candidiasis. Ann. Dentistry 52, 12-16.
8. Pasko, M. T., Piscitelli, S. C. & van Slooten, A. D. (1990) Fluconazole: a new triazole antifungal agent. DICP. Ann. Pharmacother 24, 860-867.
9. Galgiani, J. N. (1990) Fluconazole, a new antifungal agent. Ann. Intern. Med. 113, 177-179.
10. Plettenberg, A., Stoehr, A., Höffken, G. et al. (1994) Fluconazole therapy of oral candidiasis in HIV-infected patients: results of a multicentre study. Infection 22, 118-123.
11. Grant, S. M. & Clissold, S. P. (1990) Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutics potential in superficial and systemic mycoses. Drug 39, 877-916.
12. Hay, R. J. (1990) Overview of studies of fluconazole in oropharyngeal candidiasis. Rev. Infect. Dis. 12, 334-337.
13. The Status and Trends of the Global HIV/AIDS, Pandemic. (1996) Official Satellite Symposium, Int. Conference AIDS, Vancouver, Canada. Aids 10, suppl. 3.